Arcadia Biosciences Q3 2026 Results: Net Income $1.75M, Up 105.0% YoY
Arcadia Biosciences reported a net loss of $8.9 million for the nine months ended September 30, 2026, compared to a $1.0 million loss in the prior year, primarily driven by valuation losses on financing activities. Total revenues increased to $4.16 million for the nine-month period, while the company strengthened its cash position to $2.84 million through various inducement offers and PIPE financing.
- Key figure
- Net income $1.75M · +105.0% YoY